[1]
2022. Formulation and Evaluation of Orodispersible Tablet of Sulindac. European Journal of Pharmaceutical Research. 2, 3 (Dec. 2022), 11–19. DOI:https://doi.org/10.24018/ejpharma.2022.2.3.41.